|
|
|
On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic. |
|
|
|
|
| Optimizing Bioprocesses Using Functional DOE | Combining Functional Design of Experiments (Functional DOE) with traditional DOE methods enhances biopharmaceutical process optimization by capturing dynamic, time-based variations in cell culture systems. |
|
|
|
| When Science And Humanity Become Inseparable | Scientific breakthroughs mean nothing if families can’t reach them. Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study. |
|
|
| Why Human Insight Remains Essential In The Age Of AI | In an age defined by the allure of AI-driven automation and big-data analytics, technological adoption is often mistaken for innovation. Yet true competitive advantage hinges on the human capacity to think critically. |
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
